Related Experiment Video

Updated: Jun 30, 2025

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

5.2K

Treatment journey of patients with hepatocellular carcinoma using real-world data in British Columbia, Canada

Soo Jin Seung1, Hasnain Saherawala1, Brandon Zagorski2

  • 1Sunnybrook Research Institute, HOPE Research Centre, Toronto, Canada.

Hepatic Oncology
|March 18, 2024
PubMed

Insights

This study analyzed hepatocellular carcinoma (HCC) treatments in British Columbia, finding that liver transplants and systemic therapies improve survival. More Canadian cost data is needed for personalized HCC management.

Area of Science:

  • Hepatobiliary Medicine
  • Oncology
  • Health Services Research

Background:

  • Hepatocellular carcinoma (HCC) presents complex management challenges.
  • Understanding treatment patterns and outcomes is crucial for improving patient care.

Purpose of the Study:

  • To examine hepatocellular carcinoma (HCC) treatment patterns, survival outcomes, and healthcare costs in British Columbia.
  • To identify factors influencing patient journeys and treatment effectiveness.

Main Methods:

  • Utilized data from two physician databases (HCC and MOTION) and the provincial British Columbia transplant database.
  • Analyzed treatment approaches, survival rates, and associated healthcare costs.

Main Results:

  • Diverse treatment strategies for HCC were observed, with varied patient treatment journeys.
  • Liver transplant and systemic therapies were associated with improved survival outcomes.
  • A significant scarcity of Canadian-specific cost data for HCC management was identified.

Conclusions:

  • HCC management is complex, necessitating personalized treatment strategies for enhanced patient outcomes.
  • Findings offer valuable insights for optimizing HCC care and resource allocation.
  • Further research is needed to address data gaps, particularly regarding healthcare costs.
Abstract

Keywords:
CanadaHCCcosthepatocellular carcinomaresource utilizationsurvivaltreatment patterns

More Related Videos

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

422
Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization09:49

Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization

Published on: December 2, 2013

10.3K

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
345
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K